ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ABL - US0028241000 - Common Stock
106.04 EUR
-0.3 (-0.28%)
Taking everything into account, ABL scores 6 out of 10 in our fundamental rating. ABL was compared to 68 industry peers in the Health Care Equipment & Supplies industry. ABL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABL is quite expensive at the moment. It does show a decent growth rate. This makes ABL very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year ABL was profitable.
- ABL had a positive operating cash flow in the past year.
- ABL had positive earnings in each of the past 5 years.
- In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
- With an excellent Return On Assets value of 16.60%, ABL belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
- With an excellent Return On Equity value of 27.43%, ABL belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
- With a decent Return On Invested Capital value of 9.90%, ABL is doing good in the industry, outperforming 77.94% of the companies in the same industry.
- ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is in line with the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
- The Profit Margin of ABL (31.88%) is better than 100.00% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- Looking at the Operating Margin, with a value of 18.29%, ABL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- ABL has a Gross Margin (56.19%) which is in line with its industry peers.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
- The number of shares outstanding for ABL remains at a similar level compared to 1 year ago.
- The number of shares outstanding for ABL has been reduced compared to 5 years ago.
- The debt/assets ratio for ABL has been reduced compared to a year ago.
2.2 Solvency
- ABL has an Altman-Z score of 5.68. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of ABL (5.68) is better than 89.71% of its industry peers.
- ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- ABL has a Debt to FCF ratio of 1.87. This is amongst the best in the industry. ABL outperforms 80.88% of its industry peers.
- A Debt/Equity ratio of 0.23 indicates that ABL is not too dependend on debt financing.
- The Debt to Equity ratio of ABL (0.23) is better than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.68 |
ROIC/WACC1
WACC9.89%
2.3 Liquidity
- A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
- The Current ratio of ABL (1.70) is comparable to the rest of the industry.
- ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.24, ABL perfoms like the industry average, outperforming 57.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.40%, which is quite good.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
- The Revenue has been growing slightly by 6.37% in the past year.
- Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.68% on average per year.
- Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.22% on average per year.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- ABL is valuated rather expensively with a Price/Earnings ratio of 24.72.
- 70.59% of the companies in the same industry are more expensive than ABL, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (27.47), we can say ABL is valued inline with the index average.
- With a Price/Forward Earnings ratio of 21.50, ABL is valued on the expensive side.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. ABL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 21.5 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
- 61.76% of the companies in the same industry are more expensive than ABL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.99 | ||
| EV/EBITDA | 19.72 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)2.16
PEG (5Y)3.26
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
- ABL's Dividend Yield is a higher than the industry average which is at 1.09.
- ABL's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
FRA:ABL (1/16/2026, 7:00:00 PM)
106.04
-0.3 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-22 2026-01-22/amc
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap184.39B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target125.19 (18.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
Yearly Dividend1.91
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-0.21%
PT rev (3m)0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 21.5 | ||
| P/S | 4.89 | ||
| P/FCF | 30.99 | ||
| P/OCF | 23.5 | ||
| P/B | 4.21 | ||
| P/tB | 10.02 | ||
| EV/EBITDA | 19.72 |
EPS(TTM)4.29
EY4.05%
EPS(NY)4.93
Fwd EY4.65%
FCF(TTM)3.42
FCFY3.23%
OCF(TTM)4.51
OCFY4.25%
SpS21.69
BVpS25.21
TBVpS10.58
PEG (NY)2.16
PEG (5Y)3.26
Graham Number49.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.68 |
F-Score7
WACC9.89%
ROIC/WACC1
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 24.72 and the Price/Book (PB) ratio is 4.21.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 28.93%.